The presence of B cells expressing higher levels of CD38 in lymphoid organs was observed in B-CLL patients compared to in healthy individuals and was considered as a marker of disease aggressiveness [32]. The gene discussed is CD38; the disease is B-cell chronic lymphocytic leukemia.